DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,249,769 | -36.3% | 981,569 | -8.9% | 0.00% | -33.3% |
| Q2 2023 | $31,778,906 | +142.4% | 1,076,886 | +89.2% | 0.00% | +200.0% |
| Q1 2023 | $13,112,570 | +9.0% | 569,122 | +31.6% | 0.00% | 0.0% |
| Q4 2022 | $12,027,435 | -42.5% | 432,486 | -36.5% | 0.00% | -66.7% |
| Q3 2022 | $20,909,000 | +68.0% | 681,332 | +61.1% | 0.00% | +50.0% |
| Q2 2022 | $12,449,000 | -45.2% | 423,011 | -40.1% | 0.00% | -33.3% |
| Q1 2022 | $22,702,000 | +77.2% | 705,655 | +145.7% | 0.00% | +50.0% |
| Q4 2021 | $12,812,000 | -33.9% | 287,258 | -25.2% | 0.00% | -33.3% |
| Q3 2021 | $19,373,000 | -42.7% | 383,993 | -10.9% | 0.00% | -25.0% |
| Q2 2021 | $33,810,000 | +28.1% | 431,032 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $26,389,000 | +43.6% | 462,160 | +110.6% | 0.00% | +33.3% |
| Q4 2020 | $18,378,000 | +68.3% | 219,428 | -28.0% | 0.00% | +50.0% |
| Q3 2020 | $10,923,000 | +41.7% | 304,860 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $7,711,000 | +183.3% | 318,927 | +105.2% | 0.00% | +100.0% |
| Q1 2020 | $2,722,000 | -37.2% | 155,422 | -37.5% | 0.00% | 0.0% |
| Q4 2019 | $4,335,000 | +73.5% | 248,809 | +52.5% | 0.00% | 0.0% |
| Q3 2019 | $2,498,000 | -17.6% | 163,100 | +11.7% | 0.00% | 0.0% |
| Q2 2019 | $3,032,000 | -1.0% | 146,075 | +10.8% | 0.00% | 0.0% |
| Q1 2019 | $3,062,000 | -27.4% | 131,892 | -35.4% | 0.00% | 0.0% |
| Q4 2018 | $4,219,000 | +3.8% | 204,214 | +9.3% | 0.00% | 0.0% |
| Q3 2018 | $4,063,000 | +126.5% | 186,902 | +58.9% | 0.00% | – |
| Q2 2018 | $1,794,000 | +10.8% | 117,636 | +43.1% | 0.00% | – |
| Q1 2018 | $1,619,000 | +5896.3% | 82,209 | +4846.4% | 0.00% | – |
| Q4 2017 | $27,000 | – | 1,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |